AFM
OMIC

Anson Funds Management’s Singular Genomics Systems, Inc. Common Stock OMIC Stock Holding History

Anson Funds Management’s Portfolio OMIC Stock Details OMIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-5,658
Closed -$341K – 234
2022
Q4 		$341K Buy
+5,658
New +$379K 0.06% 173

Other funds holding OMIC

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Anson Funds Management's OMIC Position: Q1 2023 in Review

Anson Funds Management sold out of Singular Genomics Systems, Inc. Common Stock (OMIC) in Q1 2023, closing a stake of 5,658 shares — an estimated $341K sold.

Anson Funds Management first reported a position in OMIC in Q4 2022 and held it in 1 quarter. The position peaked at $341K in Q4 2022. 66 funds tracked by Wall St. Rank hold OMIC as of Q1 2023.

  • Anson Funds Management reported no remaining Singular Genomics Systems, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Anson Funds Management sold 5,658 Singular Genomics Systems, Inc. Common Stock shares in Q1 2023, an estimated $341K.
  • Anson Funds Management first reported a position in Singular Genomics Systems, Inc. Common Stock in Q4 2022 and held it in 1 quarter.
  • Anson Funds Management's Singular Genomics Systems, Inc. Common Stock position peaked at $341K in Q4 2022.
  • 66 funds tracked by Wall St. Rank held Singular Genomics Systems, Inc. Common Stock as of Q1 2023.

Based on Anson Funds Management's 13F filing for Q1 2023, filed 15 May 2023.